Published in J Headache Pain on November 27, 2014
Cluster headache: a quasi-rare disorder needing a reappraisal. J Headache Pain (2015) 1.01
European headache federation consensus on technical investigation for primary headache disorders. J Headache Pain (2016) 0.94
Evidence-based treatments for cluster headache. Ther Clin Risk Manag (2015) 0.85
New strategies for the treatment and prevention of primary headache disorders. Nat Rev Neurol (2016) 0.83
The Neuropharmacology of Cluster Headache and other Trigeminal Autonomic Cephalalgias. Curr Neuropharmacol (2015) 0.81
Advanced technologies and novel neurostimulation targets in trigeminal autonomic cephalalgias. Neurol Sci (2015) 0.75
O065. Drug-resistant chronic cluster headache successfully treated with supraorbital plus occipital nerve stimulation. A rare case report. J Headache Pain (2015) 0.75
Effects of non-invasive vagus nerve stimulation on attack frequency over time and expanded response rates in patients with chronic cluster headache: a post hoc analysis of the randomised, controlled PREVA study. J Headache Pain (2017) 0.75
Cluster headache attack remission with sphenopalatine ganglion stimulation: experiences in chronic cluster headache patients through 24 months. J Headache Pain (2016) 0.75
Invasive occipital nerve stimulation for refractory chronic cluster headache: what evolution at long-term? Strengths and weaknesses of the method. J Headache Pain (2016) 0.75
Pathogenesis of chronic cluster headache and bouts: role of tryptamine, arginine metabolism and α1-agonists. Neurol Sci (2017) 0.75
The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia (2013) 26.50
Epidemiology and comorbidity of headache. Lancet Neurol (2008) 2.93
EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol (2006) 2.43
Cluster headache: pathogenesis, diagnosis, and management. Lancet (2005) 1.88
Acute and preventive pharmacologic treatment of cluster headache. Neurology (2010) 1.87
Refractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation. J Headache Pain (2014) 1.53
Clinical features of unilateral headaches beyond migraine and cluster headache and their response to indomethacin. Wien Klin Wochenschr (2011) 1.47
Neuromodulation of chronic headaches: position statement from the European Headache Federation. J Headache Pain (2013) 1.39
Cluster headache in the United States of America: demographics, clinical characteristics, triggers, suicidality, and personal burden. Headache (2011) 1.24
The incidence and prevalence of cluster headache: a meta-analysis of population-based studies. Cephalalgia (2008) 1.20
Diagnostic and therapeutic errors in cluster headache: a hospital-based study. J Headache Pain (2014) 1.14
Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches. Cephalalgia (2011) 1.11
Treatment costs and indirect costs of cluster headache: A health economics analysis. Cephalalgia (2011) 1.11
Cluster headache--course over ten years in 189 patients. Cephalalgia (1991) 1.09
Epidemiology and genetics of cluster headache. Lancet Neurol (2004) 1.06
Symptomatic cluster headache: a review of 63 cases. Springerplus (2014) 0.94
Nocebo in headaches: implications for clinical practice and trial design. Curr Neurol Neurosci Rep (2012) 0.94
Cluster headache, hypothalamus, and orexin. Curr Pain Headache Rep (2009) 0.86
Carotid dissection mimicking a new attack of cluster headache. J Headache Pain (2013) 0.86
Refractory chronic headache associated with obstructive sleep apnoea syndrome. Cephalalgia (2007) 0.85
The psychiatric comorbidities of cluster headache. Curr Pain Headache Rep (2013) 0.85
Parenteral indomethacin (the INDOTEST) in cluster headache. Cephalalgia (2003) 0.84
Medication-overuse headache in patients with cluster headache. Curr Pain Headache Rep (2008) 0.82
Evidence-based interventional pain medicine according to clinical diagnoses. 2. Cluster headache. Pain Pract (2009) 0.80
Pain of a higher order: cluster headaches. Johns Hopkins Med Lett Health After 50 (2014) 0.80
Sleep apnea in patients with cluster headache: a case-control study. Cephalalgia (2014) 0.79
Cluster headache: potential options for medically refractory patients (when all else fails). Headache (2013) 0.79
The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain (2007) 4.80
Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain (2005) 4.59
'Ictal epileptic headache': recent concepts for new classifications criteria. Cephalalgia (2012) 3.19
Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review. Cephalalgia (2013) 2.87
Frovatriptan for prophylactic treatment of cluster headache: lessons for future trial design. Headache (2010) 2.72
Lifting the burden: the first 7 years. J Headache Pain (2010) 2.55
Medication overuse headache. Headache (2014) 2.37
New policies to consolidate the journal's hold on its latest position. J Headache Pain (2009) 2.33
A tier-upon-tier march towards the impact factor. J Headache Pain (2008) 2.09
Artificial niche microarrays for probing single stem cell fate in high throughput. Nat Methods (2011) 2.03
Proposals for the organisation of headache services in Europe. Intern Emerg Med (2008) 2.02
While climbing the hill, you think it's possible. J Headache Pain (2009) 1.97
Headache disorders are third cause of disability worldwide. J Headache Pain (2015) 1.93
CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol (2010) 1.88
The methodology of population surveys of headache prevalence, burden and cost: principles and recommendations from the Global Campaign against Headache. J Headache Pain (2014) 1.88
The Journal of Headache and Pain keeps gaining consensus. J Headache Pain (2010) 1.70
Diagnosis, prevalence estimation and burden measurement in population surveys of headache: presenting the HARDSHIP questionnaire. J Headache Pain (2014) 1.63
Psychiatric comorbidity in patients with chronic daily headache and migraine: a selective overview including personality traits and suicide risk. J Headache Pain (2009) 1.60
Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial. Lancet Neurol (2011) 1.58
Refractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation. J Headache Pain (2014) 1.53
The Global Campaign, World Health Organization and Lifting The Burden: collaboration in action. J Headache Pain (2011) 1.52
Effect of brief daily exercise on headache among adults--secondary analysis of a randomized controlled trial. Scand J Work Environ Health (2011) 1.52
Fathoming the kynurenine pathway in migraine: why understanding the enzymatic cascades is still critically important. Intern Emerg Med (2015) 1.52
Rehabilitating chronic migraine complicated by medication overuse headaches: how can we prevent migraine relapse? Intern Emerg Med (2010) 1.49
Time to act on headache disorders. J Headache Pain (2011) 1.47
Economic impact of primary headaches in Turkey: a university hospital based study: part II. J Headache Pain (2006) 1.45
Neurokinin-1 receptor antagonism in a rat model of subarachnoid hemorrhage: prevention of upregulation of contractile ETB and 5-HT1B receptors and cerebral blood flow reduction. J Neurosurg (2007) 1.43
Medication overuse headache. Expert Opin Drug Saf (2006) 1.42
One-year prevalence and the impact of migraine and tension-type headache in Turkey: a nationwide home-based study in adults. J Headache Pain (2012) 1.41
The definitive position of headache among the major public health challenges. An end to the slippery slope of disregard. J Headache Pain (2007) 1.40
Development and validation of the EUROLIGHT questionnaire to evaluate the burden of primary headache disorders in Europe. Cephalalgia (2010) 1.40
Neuromodulation of chronic headaches: position statement from the European Headache Federation. J Headache Pain (2013) 1.39
Chronic migraine plus medication overuse headache: two entities or not? J Headache Pain (2011) 1.39
Heregulin ameliorates the dystrophic phenotype in mdx mice. Proc Natl Acad Sci U S A (2004) 1.38
Long-term benefits of botulinum toxin type A (BOTOX) in chronic daily headache: a five-year long experience. J Headache Pain (2006) 1.38
Psychiatric comorbidity and suicide risk in patients with chronic migraine. Neuropsychiatr Dis Treat (2010) 1.37
Headache and emergency medicine: sharing a language for a common project. Intern Emerg Med (2008) 1.36
Psychometric properties of the stagnation scale in medication overuse headache patients. J Headache Pain (2015) 1.29
Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries. Neurosurgery (2003) 1.25
Cerebral ischemia upregulates vascular endothelin ET(B) receptors in rat. Stroke (2002) 1.24
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort. Mult Scler (2013) 1.22
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. J Headache Pain (2011) 1.22
Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey. Headache (2006) 1.20
Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study. J Headache Pain (2011) 1.19
Framing education on headache disorders into the Global Burden of Disease Study 2010. The European Headache Federation stands ready. J Headache Pain (2013) 1.19
Chronicling the June conundrum. J Headache Pain (2011) 1.18
UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y(6) receptors. Am J Physiol Heart Circ Physiol (2002) 1.17
The Global Burden of Disease survey 2010, Lifting The Burden and thinking outside-the-box on headache disorders. J Headache Pain (2013) 1.17
The impact of headache in Europe: principal results of the Eurolight project. J Headache Pain (2014) 1.17
MEK1/2 inhibition attenuates vascular ETA and ETB receptor alterations after cerebral ischaemia. Exp Brain Res (2006) 1.15
Cerebrovascular ETB, 5-HT1B, and AT1 receptor upregulation correlates with reduction in regional CBF after subarachnoid hemorrhage. Am J Physiol Heart Circ Physiol (2007) 1.15
Intracellular pathways involved in upregulation of vascular endothelin type B receptors in cerebral arteries of the rat. Stroke (2003) 1.15
Why HURT? A review of clinical instruments for headache management. Curr Pain Headache Rep (2012) 1.14
Enhanced expressions of microvascular smooth muscle receptors after focal cerebral ischemia occur via the MAPK MEK/ERK pathway. BMC Neurosci (2008) 1.13
Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire. Headache (2004) 1.11
Repair capacity for platinum-DNA adducts determines the severity of cisplatin-induced peripheral neuropathy. J Neurosci (2007) 1.10
Emerging treatment for chronic migraine and refractory chronic migraine. Expert Opin Emerg Drugs (2012) 1.10
Guidelines for the organization of headache education in Europe: the headache school. Funct Neurol (2005) 1.09
A six year retrospective review of occipital nerve stimulation practice--controversies and challenges of an emerging technique for treating refractory headache syndromes. J Headache Pain (2013) 1.09
Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway. J Neuroinflammation (2010) 1.09
Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature. J Cereb Blood Flow Metab (2002) 1.09
Validation of a Georgian language headache questionnaire in a population-based sample. J Headache Pain (2007) 1.08
Bone status in multiple sclerosis: beyond corticosteroids. Mult Scler (2003) 1.08
Cerebral ischemia enhances vascular angiotensin AT1 receptor-mediated contraction in rats. Stroke (2004) 1.08
Framing comorbidities and co-occurrences in a migraine with aura patient. Intern Emerg Med (2014) 1.07
Enhanced cerebrovascular expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 via the MEK/ERK pathway during cerebral ischemia in the rat. BMC Neurosci (2009) 1.06
Gene expression and molecular changes in cerebral arteries following subarachnoid hemorrhage in the rat. J Neurosurg (2006) 1.06
Prevalence of trigeminal neuralgia and persistent idiopathic facial pain: a population-based study. Cephalalgia (2011) 1.06
Medication use in patients with migraine and medication-overuse headache: the role of problem-solving and attitudes about pain medication. Pain (2011) 1.06
Prevalence and burden of primary headache in Akaki textile mill workers, Ethiopia. J Headache Pain (2008) 1.05
Importance of ERK1/2 in upregulation of endothelin type B receptors in cerebral arteries. Br J Pharmacol (2004) 1.05
Cigarette smoking leads to reduced relaxant responses of the cutaneous microcirculation. Vasc Health Risk Manag (2008) 1.05
Headache medicine: academic teaching in Europe. The Sapienza University Master's Degree. Headache (2007) 1.05